One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

A seasoned small business and technology writer and educator with more than 20 years of experience, Shweta excels in demystifying complex tech tools and concepts for small businesses. Her work has ...

MIT researchers have developed a new HIV vaccination method that generates a strong immune response with just two doses, one ...

Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week apart.

Progress in preventing infections was being made in the country with Europe's second-highest number of HIV cases. Then came ...